Quantum BioPharma Statistics
Total Valuation
QNTM has a market cap or net worth of $63.96 million. The enterprise value is $60.31 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QNTM has 3.04 million shares outstanding. The number of shares has increased by 162.08% in one year.
| Current Share Class | 3.04M |
| Shares Outstanding | 3.04M |
| Shares Change (YoY) | +162.08% |
| Shares Change (QoQ) | +24.88% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 14.12 |
| P/TBV Ratio | 70.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.96, with a Debt / Equity ratio of 0.28.
| Current Ratio | 0.96 |
| Quick Ratio | 0.67 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -46.54 |
Financial Efficiency
Return on equity (ROE) is -268.81% and return on invested capital (ROIC) is -120.32%.
| Return on Equity (ROE) | -268.81% |
| Return on Assets (ROA) | -71.24% |
| Return on Invested Capital (ROIC) | -120.32% |
| Return on Capital Employed (ROCE) | -381.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.23M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.68% in the last 52 weeks. The beta is 1.47, so QNTM's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | +86.68% |
| 50-Day Moving Average | 13.34 |
| 200-Day Moving Average | 7.25 |
| Relative Strength Index (RSI) | 54.19 |
| Average Volume (20 Days) | 428,388 |
Short Selling Information
The latest short interest is 137,945, so 4.53% of the outstanding shares have been sold short.
| Short Interest | 137,945 |
| Short Previous Month | 99,428 |
| Short % of Shares Out | 4.53% |
| Short % of Float | 5.23% |
| Short Ratio (days to cover) | 0.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.28M |
| Pretax Income | n/a |
| Net Income | -20.88M |
| EBITDA | -16.78M |
| EBIT | -17.28M |
| Earnings Per Share (EPS) | -$13.02 |
Full Income StatementBalance Sheet
The company has $3.54 million in cash and $1.28 million in debt, giving a net cash position of $2.26 million or $0.74 per share.
| Cash & Cash Equivalents | 3.54M |
| Total Debt | 1.28M |
| Net Cash | 2.26M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | 4.53M |
| Book Value Per Share | 2.11 |
| Working Capital | -412,582 |
Full Balance SheetCash Flow
| Operating Cash Flow | -9.16M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.16M |
| FCF Per Share | -$3.01 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |